Use of theragnostic markers to select drugs for phase II/III trials for Alzheimer disease.
about
Use of theragnostic markers to select drugs for phase II/III trials for Alzheimer disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Use of theragnostic markers to ...... trials for Alzheimer disease.
@en
Use of theragnostic markers to ...... trials for Alzheimer disease.
@nl
type
label
Use of theragnostic markers to ...... trials for Alzheimer disease.
@en
Use of theragnostic markers to ...... trials for Alzheimer disease.
@nl
prefLabel
Use of theragnostic markers to ...... trials for Alzheimer disease.
@en
Use of theragnostic markers to ...... trials for Alzheimer disease.
@nl
P2860
P50
P921
P356
P1476
Use of theragnostic markers to ...... trials for Alzheimer disease.
@en
P2860
P2888
P356
10.1186/ALZRT56
P407
P577
2010-11-30T00:00:00Z
P5875
P6179
1046516780